FDA Inspection
Ameriderm Laboratories, Ltd.Ameriderm Laboratories, Ltd. – FDA Inspection, Feb 13, 2013
Record Details
This FDA Inspection record concerns Ameriderm Laboratories, Ltd., with an inspection on February 13, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ameriderm Laboratories, Ltd.
- Inspection Date
- February 13, 2013
- Product Type
- Drugs
View Company Profile
ID · f69da243-e46b-4abf-9b28-54f9b26dbb9a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 818226
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
12- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.84(d)(6)Microbiological Contamination Exam
- 21 CFR 211.180(e)Records reviewed annually
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.84(b)Representative Samples Criteria
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.67(b)Written procedures not established/followed
Showing 10 of 12 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ameriderm Laboratories, Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ameriderm Laboratories, Ltd.
- FDA Inspection 733258 - 2011-06-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.